Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 962

1.

Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial.

Kimura S, Imagawa J, Murai K, Hino M, Kitawaki T, Okada M, Tanaka H, Shindo M, Kumagai T, Ikezoe T, Uoshima N, Sato T, Watanabe R, Kowata S, Hayakawa M, Hosoki T, Ikeda K, Kobayashi T, Kakinoki Y, Nishimoto T, Takezako N, Shibayama H, Takaori-Kondo A, Nakamae H, Kawaguchi A, Ureshino H, Sakamoto J, Ishida Y; DADI Trial Group.

Lancet Haematol. 2020 Jan 21. pii: S2352-3026(19)30235-2. doi: 10.1016/S2352-3026(19)30235-2. [Epub ahead of print]

PMID:
31978329
2.

Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer.

Arai S, Takeuchi S, Fukuda K, Taniguchi H, Nishiyama A, Tanimoto A, Satouchi M, Yamashita K, Ohtsubo K, Nanjo S, Kumagai T, Katayama R, Nishio M, Zheng MM, Wu YL, Nishihara H, Yamamoto T, Nakada M, Yano S.

J Thorac Oncol. 2020 Jan 20. pii: S1556-0864(20)30022-8. doi: 10.1016/j.jtho.2020.01.001. [Epub ahead of print]

3.

Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model.

Kunimasa K, Hirotsu Y, Nakamura H, Tamiya M, Iijima Y, Ishida H, Hamamoto Y, Maniwa T, Kimura T, Nishino K, Goto T, Amemiya K, Mochizuki H, Oyama T, Nakatsuka SI, Kumagai T, Okami J, Higashiyama M, Imamura F, Omata M.

Cancer Genet. 2019 Dec 25. pii: S2210-7762(19)30488-0. doi: 10.1016/j.cancergen.2019.12.006. [Epub ahead of print]

PMID:
31917104
4.

Association of Anxiety over Radiation Exposure and Acquisition of Knowledge Regarding Occupational Health Management in Operation Leader Candidates of Radioactivity Decontamination Workers in Fukushima, Japan: A Cross-Sectional Study.

Hidaka T, Kakamu T, Endo S, Kasuga H, Masuishi Y, Kumagai T, Sato S, Sasaki T, Fukushima T.

Int J Environ Res Public Health. 2019 Dec 28;17(1). pii: E228. doi: 10.3390/ijerph17010228.

5.

Treatment-free remission after first-line dasatinib treatment in patients with chronic myeloid leukemia in the chronic phase: the D-NewS Study of the Kanto CML Study Group.

Yamaguchi H, Takezako N, Ohashi K, Oba K, Kumagai T, Kozai Y, Wakita H, Yamamoto K, Fujita A, Igarashi T, Yoshida C, Ohyashiki K, Okamoto S, Sakamoto J, Sakamaki H, Inokuchi K.

Int J Hematol. 2020 Jan 1. doi: 10.1007/s12185-019-02801-z. [Epub ahead of print]

PMID:
31894533
6.

Limited stomatal regulation of the largest-size class of Dryobalanops aromatica in a Bornean tropical rainforest in response to artificial soil moisture reduction.

Yoshifuji N, Kumagai T, Ichie T, Kume T, Tateishi M, Inoue Y, Yoneyama A, Nakashizuka T.

J Plant Res. 2019 Dec 19. doi: 10.1007/s10265-019-01161-3. [Epub ahead of print]

PMID:
31858360
7.

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan.

Morita R, Okishio K, Shimizu J, Saito H, Sakai H, Kim YH, Hataji O, Yomota M, Nishio M, Aoe K, Kanai O, Kumagai T, Kibata K, Tsukamoto H, Oizumi S, Fujimoto D, Tanaka H, Mizuno K, Masuda T, Kozuki T, Haku T, Suzuki H, Okamoto I, Hoshiyama H, Ueda J, Ohe Y.

Lung Cancer. 2020 Feb;140:8-18. doi: 10.1016/j.lungcan.2019.11.014. Epub 2019 Nov 20.

8.

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer.

Nakagawa K, Hida T, Nokihara H, Morise M, Azuma K, Kim YH, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Koyama R, Mitsudomi T, Yamamoto N, Asakawa T, Hayashi M, Hasegawa W, Tamura T.

Lung Cancer. 2020 Jan;139:195-199. doi: 10.1016/j.lungcan.2019.11.025. Epub 2019 Nov 28.

PMID:
31812890
9.

Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non-small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.

Kawachi H, Tamiya M, Tamiya A, Ishii S, Hirano K, Matsumoto H, Fukuda Y, Yokoyama T, Kominami R, Fujimoto D, Hosoya K, Suzuki H, Hirashima T, Kanazu M, Sawa N, Uchida J, Morita M, Makio T, Hara S, Kumagai T.

Invest New Drugs. 2020 Feb;38(1):211-218. doi: 10.1007/s10637-019-00882-5. Epub 2019 Nov 30.

PMID:
31784866
10.

Comparison of oral microbiome profiles in stimulated and unstimulated saliva, tongue, and mouth-rinsed water.

Jo R, Nishimoto Y, Umezawa K, Yama K, Aita Y, Ichiba Y, Murakami S, Kakizawa Y, Kumagai T, Yamada T, Fukuda S.

Sci Rep. 2019 Nov 6;9(1):16124. doi: 10.1038/s41598-019-52445-6.

11.

Caregiving for Older Adults Requiring Hemodialysis: A Comparison Study.

Sugisawa H, Shinoda T, Shimizu Y, Kumagai T, Sugisaki H, Sugihara Y.

Ther Apher Dial. 2019 Nov 6. doi: 10.1111/1744-9987.13453. [Epub ahead of print]

PMID:
31693297
12.

Real-space observation of far- and near-field-induced photolysis of molecular oxygen on an Ag(110) surface by visible light.

Lin C, Ikeda K, Shiota Y, Yoshizawa K, Kumagai T.

J Chem Phys. 2019 Oct 14;151(14):144705. doi: 10.1063/1.5112158.

PMID:
31615227
13.

Disparity in pre-emptive end-of-life conversation experience caused by subjective economic status among general Japanese elderly people: a cross-sectional study with stratified random sampling.

Hidaka T, Endo S, Kasuga H, Masuishi Y, Kakamu T, Kumagai T, Saito K, Abe K, Fukushima T.

BMJ Open. 2019 Oct 7;9(10):e031681. doi: 10.1136/bmjopen-2019-031681.

14.

Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma.

Nakajima K, Kawashima I, Koshiisi M, Kumagai T, Suzuki M, Suzuki J, Mitsumori T, Kirito K.

Exp Hematol. 2019 Oct;78:46-55.e3. doi: 10.1016/j.exphem.2019.09.023. Epub 2019 Sep 24.

PMID:
31560931
15.

Extrinsic Upregulation of PD-L1 Induced by Pembrolizumab Combination Therapy in Patients with NSCLC with Low Tumor PD-L1 Expression.

Kunimasa K, Nakamura H, Nishino K, Nakatsuka SI, Kumagai T.

J Thorac Oncol. 2019 Oct;14(10):e231-e233. doi: 10.1016/j.jtho.2019.05.026. No abstract available.

PMID:
31558236
16.

Application of 2017 New Classification of Periodontal Diseases and Conditions to Localized Aggressive Periodontitis: Case Series.

Miyamoto T, Kumagai T, Khan S, Reddy MS.

Clin Adv Periodontics. 2019 Dec;9(4):185-191. doi: 10.1002/cap.10068. Epub 2019 Jul 12.

PMID:
31496127
17.

Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

Tamiya M, Tamiya A, Hosoya K, Taniguchi Y, Yokoyama T, Fukuda Y, Hirano K, Matsumoto H, Kominami R, Suzuki H, Hirashima T, Uchida J, Morita M, Kanazu M, Sawa N, Kinoshita Y, Hara S, Kumagai T, Fujimoto D.

Invest New Drugs. 2019 Dec;37(6):1266-1273. doi: 10.1007/s10637-019-00843-y. Epub 2019 Aug 7.

PMID:
31392549
18.

Endotracheal tube mucus as a source of airway mucus for rheological study.

Markovetz MR, Subramani DB, Kissner WJ, Morrison CB, Garbarine IC, Ghio A, Ramsey KA, Arora H, Kumar P, Nix DB, Kumagai T, Krunkosky TM, Krause DC, Radicioni G, Alexis NE, Kesimer M, Tiemeyer M, Boucher RC, Ehre C, Hill DB.

Am J Physiol Lung Cell Mol Physiol. 2019 Oct 1;317(4):L498-L509. doi: 10.1152/ajplung.00238.2019. Epub 2019 Aug 7.

PMID:
31389736
19.

Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.

Kubota Y, Uryu K, Ito T, Seki M, Kawai T, Isobe T, Kumagai T, Toki T, Yoshida K, Suzuki H, Kataoka K, Shiraishi Y, Chiba K, Tanaka H, Ohki K, Kiyokawa N, Kagawa J, Miyano S, Oka A, Hayashi Y, Ogawa S, Terui K, Sato A, Hata K, Ito E, Takita J.

Cancer Sci. 2019 Oct;110(10):3358-3367. doi: 10.1111/cas.14160. Epub 2019 Sep 10.

20.

Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Sugawara S, Inui N, Kanehara M, Morise M, Yoshimori K, Kumagai T, Fukui T, Minato K, Iwashima A, Takeda Y, Kubota K, Saeki T, Tamura T.

Cancer. 2019 Nov 15;125(22):4076-4083. doi: 10.1002/cncr.32429. Epub 2019 Aug 5.

21.

Resolving the Correlation between Tip-Enhanced Resonance Raman Scattering and Local Electronic States with 1 nm Resolution.

Liu S, Müller M, Sun Y, Hamada I, Hammud A, Wolf M, Kumagai T.

Nano Lett. 2019 Aug 14;19(8):5725-5731. doi: 10.1021/acs.nanolett.9b02345. Epub 2019 Aug 5.

22.

Which Is Better EGFR-TKI Followed by Osimertinib: Afatinib or Gefitinib/Erlotinib?

Tamiya M, Tamiya A, Suzuki H, Moriizumi K, Nakahama K, Taniguchi Y, Kunimasa K, Kimura M, Inoue T, Kuhara H, Nishino K, Hirashima T, Atagi S, Imamura F, Kumagai T.

Anticancer Res. 2019 Jul;39(7):3923-3929. doi: 10.21873/anticanres.13544.

PMID:
31262922
23.

Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.

Kawashima I, Kumagai T, Suzuki M, Suzuki J, Koshiishi M, Nakajima K, Kirito K.

Ann Hematol. 2019 Sep;98(9):2249-2250. doi: 10.1007/s00277-019-03733-8. Epub 2019 Jun 25. No abstract available.

PMID:
31240470
24.

Production of recombinant extracellular cholesterol esterase using consistently active promoters in Burkholderia stabilis.

Yoshida K, Konishi K, Magana-Mora A, Rougny A, Yasutake Y, Muramatsu S, Murata S, Kumagai T, Aburatani S, Sakasegawa SI, Tamura T.

Biosci Biotechnol Biochem. 2019 Oct;83(10):1974-1984. doi: 10.1080/09168451.2019.1630256. Epub 2019 Jun 19.

PMID:
31216942
25.

Whole-Genome Sequence of Monascus purpureus GB-01, an Industrial Strain for Food Colorant Production.

Kumagai T, Tsukahara M, Katayama N, Yaoi K, Aburatani S, Ohdan K, Fujimori KE.

Microbiol Resour Announc. 2019 Jun 13;8(24). pii: e00196-19. doi: 10.1128/MRA.00196-19.

26.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
27.

Electroretinograms before and after extraction of large intraocular iron foreign body.

Kumagai T, Matsumoto CS, Kimura I, Shinoda K.

Am J Ophthalmol Case Rep. 2019 May 9;15:100463. doi: 10.1016/j.ajoc.2019.100463. eCollection 2019 Sep.

28.

Developing a codon optimization method for improved expression of recombinant proteins in actinobacteria.

Saito Y, Kitagawa W, Kumagai T, Tajima N, Nishimiya Y, Tamano K, Yasutake Y, Tamura T, Kameda T.

Sci Rep. 2019 Jun 6;9(1):8338. doi: 10.1038/s41598-019-44500-z.

29.

Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.

Kaito S, Sekiya N, Najima Y, Suzuki T, Wada A, Adachi H, Konuma R, Kishida Y, Nagata A, Konishi T, Yamada Y, Kumagai T, Inamoto K, Yoshifuji K, Akiyama M, Toya T, Igarashi A, Muto H, Doki N, Kobayashi T, Kakihana K, Ohashi K.

Bone Marrow Transplant. 2019 May 29. doi: 10.1038/s41409-019-0541-1. [Epub ahead of print] No abstract available.

PMID:
31142797
30.

Psychosocial Mediators between Socioeconomic Status and Dietary Restrictions among Patients Receiving Hemodialysis in Japan.

Sugisawa H, Shinoda T, Shimizu Y, Kumagai T, Sugisaki H.

Int J Nephrol. 2019 Apr 17;2019:7647356. doi: 10.1155/2019/7647356. eCollection 2019.

31.

Bone Marrow Invasion of Small Cell Neuroendocrine Carcinoma of the Endometrium: A Diagnostic Pitfall Mimicking a Haematological Malignancy.

Kawashima I, Fukasawa H, Kasai K, Kumagai T, Koshiishi M, Nakajima K, Kondo T, Hashi A, Hirata S, Kirito K.

Intern Med. 2019 Sep 1;58(17):2561-2568. doi: 10.2169/internalmedicine.2533-18. Epub 2019 May 22.

32.

Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.

Kunimasa K, Nakamura H, Sakai K, Tamiya M, Kimura M, Inoue T, Nishino K, Kuhara H, Nakatsuka SI, Nishio K, Imamura F, Kumagai T.

Lung Cancer. 2019 Jun;132:59-64. doi: 10.1016/j.lungcan.2019.03.029. Epub 2019 Apr 8.

PMID:
31097095
33.

Associations of presence or absence of exercise and/or physical activity with non-restorative sleep by gender and age: a cross-sectional study.

Hidaka T, Endo S, Kasuga H, Masuishi Y, Kakamu T, Kumagai T, Fukushima T.

BMJ Open. 2019 May 10;9(5):e025730. doi: 10.1136/bmjopen-2018-025730.

34.

Near-Field Manipulation in a Scanning Tunneling Microscope Junction with Plasmonic Fabry-Pérot Tips.

Böckmann H, Liu S, Müller M, Hammud A, Wolf M, Kumagai T.

Nano Lett. 2019 Jun 12;19(6):3597-3602. doi: 10.1021/acs.nanolett.9b00558. Epub 2019 May 15.

35.

Factors associated with possession of accurate knowledge regarding occupational health management among operations leaders of radiation decontamination workers in Fukushima, Japan: a cross-sectional study.

Hidaka T, Kakamu T, Endo S, Kasuga H, Masuishi Y, Kumagai T, Sato S, Sasaki T, Fukushima T.

BMJ Open. 2019 May 5;9(5):e025729. doi: 10.1136/bmjopen-2018-025729.

36.

Is an immune checkpoint inhibitor really a hopeless therapeutic choice for EGFR-mutant non-small cell lung cancer (NSCLC) patients?

Kunimasa K, Nishino K, Kumagai T.

Ann Transl Med. 2019 Mar;7(Suppl 1):S32. doi: 10.21037/atm.2019.02.18. No abstract available.

37.

Feasibility of Smart Metal Artifact Reduction Algorithm on Computed Tomography Angiography for Clipping of Recurrent Aneurysms After Coil Embolization.

Kuroda H, Toyota S, Kumagai T, Iwata T, Kobayashi M, Mori K, Taki T.

World Neurosurg. 2019 Jul;127:e1249-e1254. doi: 10.1016/j.wneu.2019.04.133. Epub 2019 Apr 23.

PMID:
31026660
38.

Characteristics of awareness and behavior of medical staff for prevention of falling accidents among inpatients.

Kinoshita M, Takeda H, Yamada C, Kumagai T, Kakamu T, Hidaka T, Masuishi Y, Endo S, Hashimoto S, Fukushima T.

Fukushima J Med Sci. 2019;65(1):13-23. doi: 10.5387/fms.2018-22.

39.

Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.

Yoshifuji K, Toya T, Adachi H, Fujita M, Wada A, Konuma R, Kishida Y, Konishi T, Nagata A, Yamada Y, Kaito S, Kumagai T, Inamoto K, Akiyama M, Igarashi A, Najima Y, Doki N, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K.

Int J Hematol. 2019 Jul;110(1):115-118. doi: 10.1007/s12185-019-02622-0. Epub 2019 Apr 13.

PMID:
30989487
40.

Unhealthy changes in eating habits cause acute onset hypertension in the normotensive community-dwelling elderly-3 years cohort study.

Kakamu T, Hidaka T, Kumagai T, Masuishi Y, Kasuga H, Endo S, Sato S, Takeda A, Koizumi M, Fukushima T.

Medicine (Baltimore). 2019 Apr;98(15):e15071. doi: 10.1097/MD.0000000000015071.

41.

Electrochemical fabrication of fibrin gels via cascade reaction for cell culture.

Taira N, Ino K, Kumagai T, Nashimoto Y, Shiku H.

Chem Commun (Camb). 2019 May 10;55(37):5335-5338. doi: 10.1039/c9cc01576k. Epub 2019 Apr 10.

PMID:
30968103
42.

Near-Field Spectral Response of Optically Excited Scanning Tunneling Microscope Junctions Probed by Single-Molecule Action Spectroscopy.

Böckmann H, Müller M, Hammud A, Willinger MG, Pszona M, Waluk J, Wolf M, Kumagai T.

J Phys Chem Lett. 2019 May 2;10(9):2068-2074. doi: 10.1021/acs.jpclett.9b00822. Epub 2019 Apr 15.

43.

Serum IgM Glycosylation Associated with Tuberculosis Infection in Mice.

Kumagai T, Palacios A, Casadevall A, García MJ, Toro C, Tiemeyer M, Prados-Rosales R.

mSphere. 2019 Mar 27;4(2). pii: e00684-18. doi: 10.1128/mSphere.00684-18.

44.

Comprehensive analysis of resistance-nodulation-cell division superfamily (RND) efflux pumps from Serratia marcescens, Db10.

Toba S, Minato Y, Kondo Y, Hoshikawa K, Minagawa S, Komaki S, Kumagai T, Matoba Y, Morita D, Ogawa W, Gotoh N, Tsuchiya T, Kuroda T.

Sci Rep. 2019 Mar 19;9(1):4854. doi: 10.1038/s41598-019-41237-7.

45.

Characteristics of anxiety and the factors associated with presence or absence of each anxiety among radiation decontamination workers in Fukushima.

Kakamu T, Hidaka T, Kumagai T, Jinnouchi T, Sato S, Masuishi Y, Endo S, Nakano S, Koyama K, Fukushima T.

Ind Health. 2019 Sep 26;57(5):580-587. doi: 10.2486/indhealth.2018-0094. Epub 2019 Feb 22.

46.

Dasatinib for chronic myelogenous leukemia improves skin symptoms of systemic sclerosis.

Arai K, Yoshifuji K, Motomura Y, Sonokawa S, Suzuki S, Kumagai T.

Int J Hematol. 2019 Jun;109(6):718-722. doi: 10.1007/s12185-019-02618-w. Epub 2019 Feb 20.

PMID:
30788724
47.

Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model.

Nemoto Y, Kumagai T, Ishizawa K, Miura Y, Shiraishi T, Morimoto C, Sakai K, Omizo H, Yamazaki O, Tamura Y, Fujigaki Y, Kawachi H, Kuro-O M, Uchida S, Shibata S.

Sci Rep. 2019 Feb 11;9(1):1732. doi: 10.1038/s41598-018-38389-3.

48.

A case of Niemann-Pick disease type C with neonatal liver failure initially diagnosed as neonatal hemochromatosis.

Kumagai T, Terashima H, Uchida H, Fukuda A, Kasahara M, Kosuga M, Okuyama T, Tsunoda T, Inui A, Fujisawa T, Narita A, Eto Y, Kubota M.

Brain Dev. 2019 May;41(5):460-464. doi: 10.1016/j.braindev.2019.01.004. Epub 2019 Feb 6.

49.

Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.

Tanaka K, Toyota S, Akiyama M, Wakimoto N, Nakamura Y, Najima Y, Doki N, Kakihana K, Igarashi A, Kobayashi T, Ohashi K, Kudo D, Shinagawa A, Takano H, Fujio T, Okoshi Y, Hori M, Kumagai T, Saito T, Mukae J, Yamamoto K, Tsutsumi I, Komeno T, Yoshida C, Yamamoto M, Kojima H; on behalf of the Ochanomizu Hematology Study Group.

Acta Haematol. 2019;141(2):111-118. doi: 10.1159/000495338. Epub 2019 Feb 6.

PMID:
30726834
50.

[Chronic myeloid leukemia harboring T315I and F317L mutations successfully treated with interferon-α and ponatinib].

Motomura Y, Arai K, Yoshifuji K, Sonokawa S, Suzuki S, Kumagai T.

Rinsho Ketsueki. 2019;60(1):33-38. doi: 10.11406/rinketsu.60.33. Japanese.

PMID:
30726822

Supplemental Content

Loading ...
Support Center